|
|
leuprolide acetate The acetate salt of a synthetic nonapeptide analogue of gonadotropin-releasing hormone. Leuprolide binds to and activates gonadotropin-releasing hormone (GnRH) receptors. Continuous, prolonged administration of leuprolide in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production. This agent reduces testosterone production to castration levels and may inhibit androgen receptor-positive tumor progression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms: | | Leuprorelin Leuprorelin Acetate | | | US brand names: | | Lupron Lupron Depot Lupron Depot-3 Month Lupron Depot-4 Month Lupron Depot-Ped Viadur | | | Foreign brand names: | | Carcinil Enanton Enantone Enantone-Gyn Ginecrin Leuplin Lucrin Lucrin Depot Procren Procrin Prostap Trenantone Uno-Enantone | | | Abbreviation: | | LEUP | | | Code names: | | A-43818 Abbott 43818 TAP-144 | | | Chemical structure names: | | - 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig)
- 6-D-Leucine-9-(N-ethyl-L-prolinamide)-1-9-luteinizing Hormone-releasing Factor (Pig)
| | |
|
|